TRIal For Efficacy of Capre on hyperTriglyceridemiA

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 387 participants.

Also called NCT01455844

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 387 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01455844
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01455844. Randomized; double masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2014-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TRIal For Efficacy of Capre on hyperTriglyceridemiA
Acronym
TRIFECTA
Condition
Hypertriglyceridemia
Intervention (Drug)
CaPre (TM)
Intervention (Other)
Placebo
Intervention (Drug)
CaPre (TM)
Lead sponsor
Grace Therapeutics Inc. (class: industry)
Collaborator
JSS Medical Research Inc. (class: industry)

Record details

Record id
cardio:ct-nct01455844
Content hash
b28c1888bc9d5d28639800211b42a3973d77f0d59d2e55fb2e28ffa5e3ca2fa2